Biochemistry, Genetics and Molecular Biology
Genomics
100%
Protein Microarray
40%
Proteomics
38%
DNA Methylation
36%
Pan-cancer
35%
Cancer Cell
27%
Immunity
27%
MicroRNA
26%
Messenger RNA
22%
Oncogene
20%
Phosphotransferase
16%
Kinase
16%
Epigenetics
15%
Aneuploidy
15%
Estrogen Receptor
14%
Carcinogenesis
13%
Protein Expression
12%
Long Non-Coding RNA
12%
Stem Cell
12%
Immune Checkpoints
12%
Somatic Mutation
11%
Tumor Suppressor Protein
11%
Gene Dosage
10%
PD-L1
10%
Cell Cycle Progression
10%
Gene Mutation
10%
Gene Expression
10%
GATA3
10%
Exome
10%
Receptor Tyrosine Kinase
9%
extracellular signal regulated kinase
9%
Gene Fusion
9%
Mesenchymal-Epithelial Transition
9%
Epidermal Growth Factor Receptor
9%
Proteome
8%
Cell Cycle
8%
Transcriptomics
8%
Gene Expression Profiling
8%
FOXA1
8%
Chromosome Instability
8%
Gene Amplification
8%
Alpha Thalassemia/Mental Retardation X-Linked
8%
Colon
8%
Genetics
8%
DNA Repair
7%
Methylation
7%
Cancer Genomics
7%
Promoter Region
7%
BAP1
7%
Transcriptome
6%
Keyphrases
Cancer Genome Atlas
42%
Tumor
39%
Cancer Types
31%
Breast Cancer
25%
Molecular Characterization
24%
Pan-cancer
20%
Genome Analysis
17%
Reverse Phase Protein Array
16%
In Cancer
16%
Integrative Analysis
12%
Regret
12%
Ovarian Cancer
11%
Pan-cancer Analysis
11%
IDH mutation
11%
Molecular Classification
10%
Aneuploidy
9%
MicroRNA
9%
Tumor Suppressor
9%
Immune Checkpoint Therapy
9%
Clinical Outcomes
8%
Metastasis
8%
Metastatic Melanoma
8%
Cholangiocarcinoma
8%
Molecular Profile
8%
Proteomic Profiling
8%
Renal Carcinoma Cells
8%
Tumor Subtype
7%
Molecular Features
7%
Driver mutations
7%
Cell Proliferation
6%
MEK Inhibitor (MEKi)
6%
Non-small Cell Lung Cancer (NSCLC)
6%
Functional Proteome
6%
Genetic Modification
6%
Copy number
6%
Tumor Protein p53 (TP53)
6%
Chemotherapy
6%
Functional Consequences
6%
Cancer Growth
6%
Functional Proteomics
6%
Pathological Complete Response
6%
Programmed Death-ligand 1 (PD-L1)
5%
Estrogen Receptor-positive
5%
Genomic Analysis
5%
Cancer Cells
5%
Lysophosphatidic Acid
5%
Phosphorylation
5%
Targeted Therapy
5%
Cell Cycle Progression
5%
RNA Sequencing (RNA-seq)
5%
Medicine and Dentistry
Neoplasm
70%
Malignant Neoplasm
44%
The Cancer Genome Atlas
38%
Breast Cancer
23%
Proteomics
18%
Cancer
18%
Cancer Types
17%
Ovarian Cancer
15%
Protein Microarray
14%
microRNA
13%
Acute Myeloid Leukemia
12%
Biological Marker
10%
Cancer Cell
9%
Cell Line
9%
Messenger RNA
8%
Cell Signaling Pathway
8%
Metastatic Carcinoma
8%
Stem Cell
8%
Diseases
8%
Transitional Cell Carcinoma
8%
Mammalian Target of Rapamycin Inhibitor
8%
Clinical Trial
7%
Gene Expression
7%
Mesenchymal-Epithelial Transition
7%
Somatics
6%
extracellular signal regulated kinase
6%
Immunity
6%
Programmed Cell Death
6%
Immunotherapy
6%
Metastatic Melanoma
6%
Stroma
5%
DNA Methylation
5%
Programmed Death-Ligand 1
5%
Phosphotransferase
5%
Lysophosphatidic Acid
5%
Cancer Growth
5%
Cisplatin
5%
Carcinogenesis
5%
DNA Repair
5%
Aneuploidy
5%
Transcriptomics
5%
Clear Cell Renal Cell Carcinoma
5%
Connective Tissue Cancer
5%
